Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Asset Utilization Ratio (2017 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Asset Utilization Ratio for 9 consecutive years, with 0.07 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 89.44% to 0.07 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07 through Dec 2025, down 89.44% year-over-year, with the annual reading at 0.07 for FY2025, 91.73% down from the prior year.
  • Asset Utilization Ratio hit 0.07 in Q4 2025 for Protagonist Therapeutics, down from 0.29 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.64 in Q4 2024 to a low of 0.03 in Q4 2023.
  • Historically, Asset Utilization Ratio has averaged 0.27 across 5 years, with a median of 0.28 in 2025.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 4840.47% in 2021 and later plummeted 94.46% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.08 in 2021, then surged by 591.55% to 0.52 in 2022, then tumbled by 94.46% to 0.03 in 2023, then soared by 2087.46% to 0.64 in 2024, then tumbled by 89.44% to 0.07 in 2025.
  • Business Quant data shows Asset Utilization Ratio for PTGX at 0.07 in Q4 2025, 0.29 in Q3 2025, and 0.28 in Q2 2025.